- Home
- Publications
- Publication Search
- Publication Details
Title
Advancements in the delivery of epigenetic drugs
Authors
Keywords
-
Journal
Expert Opinion on Drug Delivery
Volume 12, Issue 9, Pages 1501-1512
Publisher
Informa Healthcare
Online
2015-03-05
DOI
10.1517/17425247.2015.1021678
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Delivery of epidrugs
- (2014) Fatima el Bahhaj et al. DRUG DISCOVERY TODAY
- Development and validation of a HILIC–MS/MS method for quantification of decitabine in human plasma by using lithium adduct detection
- (2014) Wenyi Hua et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Rewriting the Epigenetic Code for Tumor Resensitization: A Review
- (2014) Bryan Oronsky et al. Translational Oncology
- The anticancer effects of HDAC inhibitors require the immune system
- (2014) Alison C West et al. OncoImmunology
- Phase 2 study of azacytidine plus sorafenib in patients with acute myeloid leukemia and FLT-3 internal tandem duplication mutation
- (2013) F. Ravandi et al. BLOOD
- Development of a novel cell-based assay system EPISSAY for screening epigenetic drugs and liposome formulated decitabine
- (2013) Sue Ping Lim et al. BMC CANCER
- Selective biophysical interactions of surface modified nanoparticles with cancer cell lipids improve tumor targeting and gene therapy
- (2013) Blanka Sharma et al. CANCER LETTERS
- Efficacy of decitabine-loaded nanogels in overcoming cancer drug resistance is mediated via sustained DNA methyltransferase 1 (DNMT1) depletion
- (2013) Sivakumar Vijayaraghavalu et al. CANCER LETTERS
- Phase I and pharmacodynamic study of vorinostat combined with capecitabine and cisplatin as first-line chemotherapy in advanced gastric cancer
- (2013) Changhoon Yoo et al. INVESTIGATIONAL NEW DRUGS
- Prodrug/Enzyme Based Acceleration of Absorption of Hydrophobic Drugs: An in Vitro Study
- (2013) Mamta Kapoor et al. MOLECULAR PHARMACEUTICS
- The Narrow-Spectrum HDAC Inhibitor Entinostat Enhances NKG2D Expression Without NK Cell Toxicity, Leading to Enhanced Recognition of Cancer Cells
- (2013) Shiguo Zhu et al. PHARMACEUTICAL RESEARCH
- Pharmacokinetic and pharmacodynamic analysis of 5-aza-2’-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy
- (2013) Metin Karahoca et al. Clinical Epigenetics
- Nanoparticle and targeted systems for cancer therapy
- (2012) Lisa Brannon-Peppas et al. ADVANCED DRUG DELIVERY REVIEWS
- Liposomal drug delivery systems: From concept to clinical applications
- (2012) Theresa M. Allen et al. ADVANCED DRUG DELIVERY REVIEWS
- Current limitations and future opportunities for epigenetic therapies
- (2012) F Cherblanc et al. Future Medicinal Chemistry
- Randomized Phase II Trial of Erlotinib With and Without Entinostat in Patients With Advanced Non–Small-Cell Lung Cancer Who Progressed on Prior Chemotherapy
- (2012) Samir E. Witta et al. JOURNAL OF CLINICAL ONCOLOGY
- Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia
- (2012) Hagop M. Kantarjian et al. JOURNAL OF CLINICAL ONCOLOGY
- A randomized controlled trial of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving decitabine
- (2012) Peter L. Greenberg et al. LEUKEMIA & LYMPHOMA
- Highly Synergistic Effect of Sequential Treatment with Epigenetic and Anticancer Drugs To Overcome Drug Resistance in Breast Cancer Cells Is Mediated via Activation of p21 Gene Expression Leading to G2/M Cycle Arrest
- (2012) Sivakumar Vijayaraghavalu et al. MOLECULAR PHARMACEUTICS
- Association of Chemotherapeutic Drugs with Dendrimer Nanocarriers: An Assessment of the Merits of Covalent Conjugation Compared to Noncovalent Encapsulation
- (2012) Lisa M. Kaminskas et al. MOLECULAR PHARMACEUTICS
- Epigenetic protein families: a new frontier for drug discovery
- (2012) Cheryl H. Arrowsmith et al. NATURE REVIEWS DRUG DISCOVERY
- Functions of DNA methylation: islands, start sites, gene bodies and beyond
- (2012) Peter A. Jones NATURE REVIEWS GENETICS
- DNA Methylation and Its Basic Function
- (2012) Lisa D Moore et al. NEUROPSYCHOPHARMACOLOGY
- Sirtuins and Disease: The Road Ahead
- (2012) Vincenzo Carafa et al. Frontiers in Pharmacology
- Nanoparticle Delivery of Cancer Drugs
- (2011) Andrew Z. Wang et al. Annual Review of Medicine
- Effects of tetrahydrouridine on pharmacokinetics and pharmacodynamics of oral decitabine
- (2011) D. Lavelle et al. BLOOD
- A pilot study of subcutaneous decitabine in -thalassemia intermedia
- (2011) N. F. Olivieri et al. BLOOD
- Regulation of chromatin by histone modifications
- (2011) Andrew J Bannister et al. CELL RESEARCH
- Epigenetics in disease: Leader or follower?
- (2011) David I.K. Martin et al. Epigenetics
- Death Receptor Pathway Activation and Increase of ROS Production by the Triple Epigenetic Inhibitor UVI5008
- (2011) A. Nebbioso et al. MOLECULAR CANCER THERAPEUTICS
- Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study
- (2011) B. B. Friday et al. NEURO-ONCOLOGY
- The HDAC class I-specific inhibitor entinostat (MS-275) effectively relieves epigenetic silencing of the LAT2 gene mediated by AML1/ETO
- (2011) J Duque-Afonso et al. ONCOGENE
- Cellular Uptake, Intracellular Trafficking, and Cytotoxicity of Nanomaterials
- (2011) Feng Zhao et al. Small
- Stimulus responsive nanogels for drug delivery
- (2011) Liusheng Zha et al. Soft Matter
- Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
- (2011) Hirenkumar K. Makadia et al. Polymers
- 5-Azacytidine in chronic myelomonocytic leukemia: case report and review of literature
- (2011) Mariangela Greco et al. Mediterranean Journal of Hematology and Infectious Diseases
- Tumor-Selective Delivery of Macromolecular Drugs via the EPR Effect: Background and Future Prospects
- (2010) Hiroshi Maeda BIOCONJUGATE CHEMISTRY
- Epigenetic profiling of the antitumor natural product psammaplin A and its analogues
- (2010) José García et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Novel treatment strategies for patients with relapsed classical Hodgkin lymphoma
- (2010) Adam Jona et al. BLOOD REVIEWS
- Pharmacokinetic and pharmacodynamic properties of an oral formulation of the histone deacetylase inhibitor Belinostat (PXD101)
- (2010) N. L. Steele et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- 5-Azacytidine in myelodysplastic syndromes: A clinical practice guideline
- (2010) Rena Buckstein et al. CANCER TREATMENT REVIEWS
- Thelet-7microRNA reduces tumor growth in mouse models of lung cancer
- (2010) Aurora Esquela-Kerscher et al. CELL CYCLE
- To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
- (2010) Fabienne Danhier et al. JOURNAL OF CONTROLLED RELEASE
- Delivery of 5-Azacytidine to Human Cancer Cells by Elaidic Acid Esterification Increases Therapeutic Drug Efficacy
- (2010) B. Brueckner et al. MOLECULAR CANCER THERAPEUTICS
- A Comparison of Azacitidine and Decitabine Activities in Acute Myeloid Leukemia Cell Lines
- (2010) Paul W. Hollenbach et al. PLoS One
- siRNA delivery systems for cancer treatment
- (2009) Yu-Kyoung Oh et al. ADVANCED DRUG DELIVERY REVIEWS
- Gene-body hypermethylation of ATM in peripheral blood DNA of bilateral breast cancer patients
- (2009) James M. Flanagan et al. HUMAN MOLECULAR GENETICS
- Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies
- (2009) Rocio G Urdinguio et al. LANCET NEUROLOGY
- Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse
- (2009) Patrick O McGowan et al. NATURE NEUROSCIENCE
- Integrative Analysis of Epigenetic Modulation in Melanoma Cell Response to Decitabine: Clinical Implications
- (2009) Ruth Halaban et al. PLoS One
- Evolution of decitabine development
- (2008) Elias Jabbour et al. CANCER
- Phase I Study of Epigenetic Modulation with 5-Azacytidine and Valproic Acid in Patients with Advanced Cancers
- (2008) F. Braiteh et al. CLINICAL CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started